¿Û¿Û´«Ã½

A pharma stock emerging from Novo Nordisk's shadow

Denmark’s second-largest pharma group is poised to reap the rewards of a successful reorganisation

A UK mid cap living the American dream

Investors are underestimating this plucky market consolidator

This data giant has a bright and growth-filled future

This quality stock's smart pivot into consumer services is more than offsetting slowing demand for its traditional business line

This retailer is on the up – and is a prime takeover target

Home improvement chain is gaining market share and stands to profit as the sector improves

Overvalued and underperforming: it's time to ditch Tesla

Elon Musk's electric car maker needs everything to go perfectly to justify its massive valuation

This trust is now a better way to buy global shares

The fund benefits from Baillie Gifford’s bold attitude but a portfolio shake-up has made it much more appealing to investors

Mining is becoming harder – but this stock ticks a lot of boxes

The copper market could be in deficit just as this company hikes its output

How our InvestorsChronicle of the Week fared last year

From chief executives being detained to sell calls gone wrong, here's how our 100 buy and sell InvestorsChronicle did in 2024

Investment InvestorsChronicle of the Year 2024 Review

Last year’s annual picks delivered, in both absolute and relative terms, and in their consistency

A US superstar trading at a discount

The company is defying fears about the threat of artificial intelligence